Our Community

Quantum-safe communication remains one of the hardest verticals in deep tech to commercialise anywhere in the world — India included. Most ventures in this category are still working through lab-stage physics. A small cohort, however, is now making the harder transition: from R&D roadmap to fielded, revenue-generating product, taking made-in-India quantum technology into the global arena. Bengaluru-based QNu Labs is one of them — and it is making that transition visible. As c

India's chip design industry has spent three decades exporting talent, not products: engineers who design silicon for Qualcomm, Intel, and Nvidia while the domestic market runs on imported chips. In June this year , that pattern broke a little further. Mindgrove Technologies, a Speciale portfolio company, has signed a commercial deployment agreement with Prama India to embed its indigenously designed Vision SoC into Prama's CCTV and video security product line. It is a small

In May this year, two years after its historic tech demonstrator flight — the first rocket in the world powered by a single-piece 3D-printed engine — AgniKul Cosmos delivered its next major proof point. On May 19, the Chennai-based launch vehicle company successfully completed a simultaneous hot-fire test of its four Agnilet engine semi-cryogenic cluster: eight pumps, eight motors, synchronized by independent algorithms, operating as a single coherent propulsion unit. This wa

When Uravu Labs was selected for Abu Dhabi's Hub71 Cohort 18, the headline read like a geographic milestone. But for those of us who backed this Bengaluru-based deep-tech startup from its earliest days, the news carried a more significant signal: a technology developed, stress-tested, and commercialised in India is now being sought out by one of the world's most water-stressed and capital-intensive regions. This is not simply expansion. It is validation — of a fundamental tec

There’s a quiet but profound transformation building at the hardware-software boundary — below the applications layer where most AI productivity tools play, and deep in the firmware that actually makes silicon do things. This is where H2Loop is staking its claim. H2Loop’s recent close of a $2 million seed round, co-led by Speciale Invest and 3one4 Capital, validates a thesis we’ve held for some time: the next frontier of productivity lies not in general-purpose models, but in

The name alone should give you a hint. Morphing Machines. Shapeshifters. And in the world of silicon, that is precisely what they are — a Bengaluru-based fabless semiconductor startup building processors that physically reconfigure themselves in real-time to match the demands of a workload. After nearly two decades incubating at the Indian Institute of Science (IISc), Morphing Machines has crossed a critical threshold: a Rs. 80 crore (approximately $11.6 million) Series A rou

A Staircase Worth Climbing If you skip the elevator at Newtrace's R&D facility in Bengaluru and take the stairs, every step greets you with a sticker — a hydrogen factoid. How much of it humanity consumes. How much carbon the current production methods emit. How far the gap stretches between where we are and where we need to be. It's a small detail, but it tells you something important about the founders: Prasanta Sarkar and Rochan Sinha are not building a company for a pitch

At Speciale Invest, we back founders solving problems the rest of the world has decided are too hard. Nucleovir Therapeutics is exactly that kind of company — and this is the story of why we invested. The unfinished business of immunotherapy A decade ago, immunotherapy rewrote what was possible in cancer. Instead of poisoning tumors directly, a new class of drugs, checkpoint inhibitors like Keytruda and Opdivo, taught the body's own immune system to do the killing. They took

Why India needs full-stack health data infrastructure to extend healthy lifespan — and how the right startups can make it happen India's path to longer, healthier lives will be built on unglamorous foundations: interoperable records, clean diagnostics, and software that makes both actionable at the point of care. Not wearables, not longevity clinics, not AI chatbots promising personalised wellness; Infrastructure. This distinction matters because it shapes where durable value